EN UNA EMPRESA EN LA QUE HAY CABILDER@S , ONCOLOG@S , CIENTÍFIC@S , GURUS , ANALISTAS , FONDOS ... CON CONFLICTO DE INTERES ... SIEMPRE HABRA UN DISCURSO ÚNICO ...
Trabectedin (Yondelis®). This drug binds to DNA and interacts with DNA repair enzymes to disrupt the cell cycle. It has demonstrated good clinical activity in Phase III trials of patients with ovarian cancer.